NMS-03597812

DRUG2 trials

Sponsors

Nerviano Medical Sciences

Conditions

Multiple MyelomaRelapsed/Refractory Acute Myeloid Leukemia

Phase 1

Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma

TerminatedNCT05027594

Nerviano Medical SciencesMultiple Myeloma

Start: 2022-09-09End: 2024-01-08Updated: 2025-06-13

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingNCT06549790

Nerviano Medical SciencesRelapsed/Refractory Acute Myeloid Leukemia

Start: 2024-10-16End: 2030-05-15Target: 124Updated: 2025-10-31